FDA Inspection 882445 — Catalent Pharma Solutions, LLC

Catalent Pharma Solutions, LLC — FEI 3007617094

The FDA completed an inspection of Catalent Pharma Solutions, LLC on Jun 10, 2014 in Philadelphia, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Jun 10, 2014
Fiscal Year
2014
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Philadelphia, PA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.